Journal of the National Cancer Institute
News brief: Knockdown of E2F1 reduces invasive potential of melanoma cells
Published in Drug Week, January 15th, 2010
To investigate E2F1's role in cancer progression, Brigitte M. Putzer, M.D., Ph.D., of the department of vectorology and experimental gene therapy at the University Rostock in Germany, and colleagues used E2F1 gene silencing in melanoma cells and in mice to compare cell growth and invasive potential and tumor growth and formation of metastatic lesions. The authors also examined...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
Source: Drug Week (2010-01-15)
More Articles from Drug Week
- American Academy of Neurology
Guideline: Widely used device for pain therapy not recommended for chronic low back pain - American Associates, Ben-Gurion University of the Negev
Anti-inflammatory drugs coxibs interfere with aspirin's clotting ability -- Ben-Gurion U. - Institute for Research in Biomedicine IRB Barcelona
Researchers design a tool to induce controlled suicide in human cells - JAMA and Archives Journals
Findings suggest cardiovascular devices often approved by FDA without high-quality studies - Journal of the National Cancer Institute
Assessing lead time of selected ovarian cancer biomarkers - National Institute on Deafness
Gene linked to a rare form of progressive hearing loss in males is identified - More from this issue of Drug Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
